CN1430503A - 制剂 - Google Patents

制剂 Download PDF

Info

Publication number
CN1430503A
CN1430503A CN01810092A CN01810092A CN1430503A CN 1430503 A CN1430503 A CN 1430503A CN 01810092 A CN01810092 A CN 01810092A CN 01810092 A CN01810092 A CN 01810092A CN 1430503 A CN1430503 A CN 1430503A
Authority
CN
China
Prior art keywords
pharmaceutical composition
water
sterile pharmaceutical
oil
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01810092A
Other languages
English (en)
Chinese (zh)
Inventor
D·B·古德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1430503A publication Critical patent/CN1430503A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Colloid Chemistry (AREA)
  • Edible Oils And Fats (AREA)
CN01810092A 2000-05-25 2001-05-22 制剂 Pending CN1430503A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012597.1A GB0012597D0 (en) 2000-05-25 2000-05-25 Formulation
GB0012597.1 2000-05-25

Publications (1)

Publication Number Publication Date
CN1430503A true CN1430503A (zh) 2003-07-16

Family

ID=9892262

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01810092A Pending CN1430503A (zh) 2000-05-25 2001-05-22 制剂

Country Status (18)

Country Link
US (3) US20030144356A1 (https=)
EP (1) EP1289503B1 (https=)
JP (1) JP2003535057A (https=)
KR (1) KR20030009501A (https=)
CN (1) CN1430503A (https=)
AT (1) ATE365538T1 (https=)
AU (2) AU5858801A (https=)
BR (1) BR0111136A (https=)
CA (1) CA2407764A1 (https=)
DE (1) DE60129134T2 (https=)
ES (1) ES2287128T3 (https=)
GB (1) GB0012597D0 (https=)
IL (1) IL152773A0 (https=)
MX (1) MXPA02011532A (https=)
NO (1) NO20025629L (https=)
NZ (1) NZ522365A (https=)
WO (1) WO2001089474A2 (https=)
ZA (1) ZA200208853B (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
CN101411685B (zh) * 2007-10-19 2011-04-20 上海医药工业研究院 一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
CN102366404A (zh) * 2011-10-20 2012-03-07 四川百利药业有限责任公司 一种丙泊酚中/长链脂肪乳剂
WO2014033751A3 (en) * 2012-08-16 2014-05-30 Emcure Pharmaceuticals Limited Pharmaceutical composition of propofol

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166368C (zh) * 2003-02-26 2004-09-15 刘威 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
BRPI0512864B8 (pt) * 2004-07-01 2021-05-25 Johnson & Johnson Vision Care composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição
KR20080043793A (ko) * 2005-08-05 2008-05-19 바라트 쎄럼스 앤드 백신스 리미티드 방부 효능을 갖는 정맥 프로포폴 에멀젼 조성물
US20070149617A1 (en) * 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
WO2008036353A2 (en) * 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
US20110086914A1 (en) * 2009-10-13 2011-04-14 Bailes Julian E Methods for Treating Traumatic Brain Injury
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
US9675572B2 (en) 2010-04-23 2017-06-13 The United States Of America As Represented By The Secretary Of The Army Intravenous omega-3 fatty acid compositions and method of use
US11236351B2 (en) 2010-05-17 2022-02-01 Dow Agrosciences Llc Production of DHA and other LC PUFAs in plants
WO2011149854A2 (en) * 2010-05-25 2011-12-01 Eric Kuhrts Stable formulations of fatty acids
EP2590625B1 (en) * 2010-07-06 2017-09-20 GlaxoSmithKline Biologicals SA Cationic oil-in-water emulsions
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2627173B2 (en) 2010-10-12 2018-07-04 Chiesi Farmaceutici S.p.A. Clevidipine emulsion formulations containing antimicrobial agents
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
HRP20171431T1 (hr) * 2011-06-15 2017-12-15 Stable Solutions Llc Terapijska parenteralna primjena krilovog ulja
US10052352B2 (en) 2011-06-15 2018-08-21 Stable Solutions Llc Therapeutic application of parenteral krill oil
TW201307553A (zh) * 2011-07-26 2013-02-16 Dow Agrosciences Llc 在植物中生產二十二碳六烯酸（ｄｈａ）及其他長鏈多元不飽和脂肪酸（ｌｃ－ｐｕｆａ）之技術
EP2978307B1 (en) 2013-03-28 2018-12-26 The Trustees of Columbia University in the City of New York Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
ES2607715B1 (es) * 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637404A (en) * 1992-01-31 1997-06-10 Aluminum Company Of America Reflective aluminum strip
US5478414A (en) * 1992-01-31 1995-12-26 Aluminum Company Of America Reflective aluminum strip, protected with fluoropolymer coating and a laminate of the strip with a thermoplastic polymer
BR9506681A (pt) * 1994-02-04 1997-11-18 Scotia Lipidteknik Ab Emulsão oleo em água e composição farmacêutica
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
CN101411685B (zh) * 2007-10-19 2011-04-20 上海医药工业研究院 一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
CN102366404A (zh) * 2011-10-20 2012-03-07 四川百利药业有限责任公司 一种丙泊酚中/长链脂肪乳剂
CN102366404B (zh) * 2011-10-20 2015-10-07 四川百利药业有限责任公司 一种丙泊酚中/长链脂肪乳剂
WO2014033751A3 (en) * 2012-08-16 2014-05-30 Emcure Pharmaceuticals Limited Pharmaceutical composition of propofol

Also Published As

Publication number Publication date
WO2001089474A2 (en) 2001-11-29
AU2001258588B2 (en) 2005-05-19
EP1289503A2 (en) 2003-03-12
US20080312338A1 (en) 2008-12-18
ZA200208853B (en) 2004-02-19
BR0111136A (pt) 2003-04-08
ES2287128T3 (es) 2007-12-16
MXPA02011532A (es) 2003-04-25
CA2407764A1 (en) 2001-11-29
GB0012597D0 (en) 2000-07-12
IL152773A0 (en) 2003-06-24
AU5858801A (en) 2001-12-03
ATE365538T1 (de) 2007-07-15
WO2001089474A3 (en) 2002-03-07
KR20030009501A (ko) 2003-01-29
NZ522365A (en) 2004-09-24
DE60129134T2 (de) 2008-02-28
US20060257433A1 (en) 2006-11-16
EP1289503B1 (en) 2007-06-27
US20030144356A1 (en) 2003-07-31
JP2003535057A (ja) 2003-11-25
NO20025629D0 (no) 2002-11-22
DE60129134D1 (en) 2007-08-09
NO20025629L (no) 2003-01-08

Similar Documents

Publication Publication Date Title
CN1430503A (zh) 制剂
AU2001258588A1 (en) O/W emulsion
RU2147432C1 (ru) Эмульсии типа масло в воде, содержащие пропофол и эдетат
KR102027613B1 (ko) 호르몬 함유 유화액
EP2405895B1 (en) Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
RU2625760C2 (ru) Терапевтическое применение масла криля
JP2003535884A (ja) プロポフォールの改善された注射可能な分散物
DE3903056A1 (de) Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
EP2355813B1 (de) Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten
US20100130619A1 (en) Pharmaceutical composition for parenteral administration of idebenone
CN116407543B (zh) Epa-ee纳米脂质组合物、及其制剂、制备方法和应用
CN105939705A (zh) 用于肠胃外给药的包含epa甘油三酯和dha甘油三酯的组合物
CN105939706A (zh) 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物
EP0651995A1 (de) Cyclosporin(e) enthaltende o/w Emulsion zur oralen Verabreichung
CN1217657C (zh) 存活效益
CN1287773C (zh) 一种鸦胆子油软胶囊制剂
CN1106192C (zh) 含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
JP2002541087A (ja) 防腐添加剤を含有するプロポフォール組成物
CN113559060B (zh) 蜂胶磷脂复合物的亚微乳剂及其制备方法
JPH04154724A (ja) 活性型ビタミンｄ↓３化合物含有脂肪乳剤
CN1698836A (zh) 雪上一枝蒿总生物碱乳剂组合物
CN101002732A (zh) 无菌医药组合物
HK1008927B (en) Oil in water emulsions containing propofol and edetate
HK1087642B (en) Sterile pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20030716